Picture of Starpharma Holdings logo

SPL Starpharma Holdings Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Starpharma Holdings, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital5.827.468.338.348.78
Other Operating Cash Flow
Cash from Operating Activities-10.8-14.8-13.2-13.5-6.98
Capital Expenditures-0.125-0.246-0.837-0.621-0.089
Purchase of Fixed Assets
Other Investing Cash Flow Items000.0010.0110
Sale/Maturity of Investment
Cash from Investing Activities-0.125-0.246-0.836-0.61-0.089
Financing Cash Flow Items-1.930
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.58446.33.23-0.695-4.75
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-11.230.4-10.6-14.7-11.8